<?xml version='1.0' encoding='utf-8' ?>
<!--  If you are running a bot please visit this policy page outlining rules you must respect. http://www.insanejournal.com/bots/  -->
<rss version='2.0' xmlns:lj='http://www.livejournal.org/rss/lj/1.0/'>
<channel>
  <title>pazopanibbrown1</title>
  <link>http://pazopanibbrown1.insanejournal.com/</link>
  <description>pazopanibbrown1 - InsaneJournal</description>
  <managingEditor>pazopanib@yahoo.co.uk</managingEditor>
  <lastBuildDate>Tue, 13 Mar 2012 03:20:37 GMT</lastBuildDate>
  <generator>LiveJournal / InsaneJournal</generator>
<item>
  <guid isPermaLink='true'>http://pazopanibbrown1.insanejournal.com/1165.html</guid>
  <pubDate>Tue, 13 Mar 2012 03:20:37 GMT</pubDate>
  <title>angiogenesis inhibitor,TSA hdac inhibitor,GSK1363089 assess the safety of afatinib good incidence of</title>
  <author>pazopanib@yahoo.co.uk</author>  <link>http://pazopanibbrown1.insanejournal.com/1165.html</link>
  <description>The Phase I step about this study was, therefore, performed to look for the maxi &lt;b&gt;(&lt;a href=&quot;http://pazopanibbrown1.insanejournal.com/1165.html&quot;&gt;Read more ...&lt;/a&gt;)&lt;/b&gt;</description>
  <comments>http://pazopanibbrown1.insanejournal.com/1165.html</comments>
  <category>tsa hdac inhibitor</category>
  <category>angiogenesis inhibitors</category>
  <category>angiogenesis inhibitor</category>
  <category>gsk1363089</category>
  <lj:security>public</lj:security>
</item>
<item>
  <guid isPermaLink='true'>http://pazopanibbrown1.insanejournal.com/954.html</guid>
  <pubDate>Mon, 16 Jan 2012 03:26:26 GMT</pubDate>
  <title>angiogenesis inhibitor AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment </title>
  <author>pazopanib@yahoo.co.uk</author>  <link>http://pazopanibbrown1.insanejournal.com/954.html</link>
  <description>AC220 is a novel compound expressly optimized for a FLT3 inhibitor for dealing w &lt;b&gt;(&lt;a href=&quot;http://pazopanibbrown1.insanejournal.com/954.html&quot;&gt;Read more ...&lt;/a&gt;)&lt;/b&gt;</description>
  <comments>http://pazopanibbrown1.insanejournal.com/954.html</comments>
  <category>angiogenesis inhibitors</category>
  <category>angiogenesis inhibitor</category>
  <category>pazopanib</category>
  <category>ac220</category>
  <lj:security>public</lj:security>
</item>
<item>
  <guid isPermaLink='true'>http://pazopanibbrown1.insanejournal.com/558.html</guid>
  <pubDate>Tue, 03 Jan 2012 02:41:46 GMT</pubDate>
  <title>A chemical that inhibits the signals Pazopanib, Crizotinib is known as an angiogenesis inhibitor.</title>
  <author>pazopanib@yahoo.co.uk</author>  <link>http://pazopanibbrown1.insanejournal.com/558.html</link>
  <description>Research appearing out of the Lung Cancer Mutation Consortium has revealed that  &lt;b&gt;(&lt;a href=&quot;http://pazopanibbrown1.insanejournal.com/558.html&quot;&gt;Read more ...&lt;/a&gt;)&lt;/b&gt;</description>
  <comments>http://pazopanibbrown1.insanejournal.com/558.html</comments>
  <category>angiogenesis inhibitors</category>
  <category>angiogenesis inhibitor</category>
  <category>crizotinib</category>
  <category>pazopanib</category>
  <lj:security>public</lj:security>
</item>
<item>
  <guid isPermaLink='true'>http://pazopanibbrown1.insanejournal.com/371.html</guid>
  <pubDate>Thu, 22 Dec 2011 05:20:06 GMT</pubDate>
  <title>A cancer treatment being studied at crizotinib - The Treatment Of Drenched Age-Related Macular Degen</title>
  <author>pazopanib@yahoo.co.uk</author>  <link>http://pazopanibbrown1.insanejournal.com/371.html</link>
  <description>&quot;Lucentis provides new traumas patients with wet AMD because it&apos;s the first ther &lt;b&gt;(&lt;a href=&quot;http://pazopanibbrown1.insanejournal.com/371.html&quot;&gt;Read more ...&lt;/a&gt;)&lt;/b&gt;</description>
  <comments>http://pazopanibbrown1.insanejournal.com/371.html</comments>
  <category>angiogenesis inhibitor</category>
  <category>crizotinib</category>
  <category>pazopanib</category>
  <lj:security>public</lj:security>
</item>
</channel>
</rss>

